Cargando…
In silico drug repositioning based on the integration of chemical, genomic and pharmacological spaces
BACKGROUND: Drug repositioning refers to the identification of new indications for existing drugs. Drug-based inference methods for drug repositioning apply some unique features of drugs for new indication prediction. Complementary information is provided by these different features. It is therefore...
Autores principales: | Chen, Hailin, Zhang, Zuping, Zhang, Jingpu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868667/ https://www.ncbi.nlm.nih.gov/pubmed/33557749 http://dx.doi.org/10.1186/s12859-021-03988-x |
Ejemplares similares
-
In silico drug repositioning based on integrated drug targets and canonical correlation analysis
por: Chen, Hailin, et al.
Publicado: (2022) -
Network-Based Inference Methods for Drug Repositioning
por: Chen, Hailin, et al.
Publicado: (2015) -
A miRNA-Driven Inference Model to Construct Potential Drug-Disease Associations for Drug Repositioning
por: Chen, Hailin, et al.
Publicado: (2015) -
A Review of Current In Silico Methods for Repositioning Drugs and Chemical Compounds
por: He, Binsheng, et al.
Publicado: (2021) -
Rational drug repositioning guided by an integrated pharmacological network of protein, disease and drug
por: Lee, Hee Sook, et al.
Publicado: (2012)